LB54640

DB18331InvestigationalSmall molecule

LB54640 is orally-administered small molecule agonist of the melanocortin 4 receptor.

Code names
LB-54640

What you can answer from here — as of April 23, 2025

3Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of LB54640, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In